Positioning biologics—A case-based discussion: Surgery and clinical trials

Réme Mountifield

doi:10.1111/jgh.14424

Positioning biologics—A case-based discussion: Surgery and clinical trials

Réme Mountifield

College of Medicine and Public Health

Research output: Contribution to journal › Article › peer-review

Abstract

The first case presented was a young male with a history of extensive small intestinal resection for Crohn's disease with recurrent inflammation despite immunosuppressant therapy and vedolizumab.

Original language	English
Pages (from-to)	18
Number of pages	1
Journal	Journal of Gastroenterology and Hepatology (Australia)
Volume	33
DOIs	https://doi.org/10.1111/jgh.14424
Publication status	Published - 5 Sept 2018
Event	Proceedings of the Takeda Symposium - Pan Pacific Hotel, Melbourne, Australia Duration: 17 Mar 2018 → 18 Mar 2018

Keywords

Biologics
Surgery
Clinical trials
Inflammatory bowel disease

Access to Document

10.1111/jgh.14424Licence: In Copyright

Cite this

@article{4309aa2e11144350a3d9d053f1588aac,

title = "Positioning biologics—A case-based discussion: Surgery and clinical trials",

abstract = "The first case presented was a young male with a history of extensive small intestinal resection for Crohn's disease with recurrent inflammation despite immunosuppressant therapy and vedolizumab.",

keywords = "Biologics, Surgery, Clinical trials, Inflammatory bowel disease",

author = "R{\'e}me Mountifield",

year = "2018",

month = sep,

day = "5",

doi = "10.1111/jgh.14424",

language = "English",

volume = "33",

pages = "18",

journal = "Journal of Gastroenterology and Hepatology (Australia)",

issn = "0815-9319",

publisher = "John Wiley & Sons, Inc",

note = "Proceedings of the Takeda Symposium ; Conference date: 17-03-2018 Through 18-03-2018",

}

TY - JOUR

T1 - Positioning biologics—A case-based discussion

T2 - Proceedings of the Takeda Symposium

AU - Mountifield, Réme

PY - 2018/9/5

Y1 - 2018/9/5

N2 - The first case presented was a young male with a history of extensive small intestinal resection for Crohn's disease with recurrent inflammation despite immunosuppressant therapy and vedolizumab.

AB - The first case presented was a young male with a history of extensive small intestinal resection for Crohn's disease with recurrent inflammation despite immunosuppressant therapy and vedolizumab.

KW - Biologics

KW - Surgery

KW - Clinical trials

KW - Inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=85052818611&partnerID=8YFLogxK

U2 - 10.1111/jgh.14424

DO - 10.1111/jgh.14424

M3 - Article

C2 - 30187546

AN - SCOPUS:85052818611

SN - 0815-9319

VL - 33

SP - 18

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

Y2 - 17 March 2018 through 18 March 2018

ER -

Positioning biologics—A case-based discussion: Surgery and clinical trials

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this